Prednisone Completed Phase 2 Trials for Nephritis, Lupus Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02260934Rituximab and Belimumab for Lupus Nephritis
NCT01085097Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
NCT00423098Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare